Comment on "ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma."
Clin Mol Hepatol. 2023 Oct 13. doi: 10.3350/cmh.2023.0394. Online ahead of print.NO ABSTRACTPMID:37828840 | DOI:10.3350/cmh.2023.0394 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - October 13, 2023 Category: Gastroenterology Authors: Hinpetch Daungsupawong Viroj Wiwanitkit Source Type: research

Recent Updates on Pharmacologic Therapy in Nonalcoholic Fatty Liver Disease
Clin Mol Hepatol. 2023 Oct 13. doi: 10.3350/cmh.2023.0356. Online ahead of print.NO ABSTRACTPMID:37828839 | DOI:10.3350/cmh.2023.0356 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - October 13, 2023 Category: Gastroenterology Authors: Young Chang Soung Won Jeong Jae Young Jang Source Type: research

Comment on "ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma."
Clin Mol Hepatol. 2023 Oct 13. doi: 10.3350/cmh.2023.0394. Online ahead of print.NO ABSTRACTPMID:37828840 | DOI:10.3350/cmh.2023.0394 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - October 13, 2023 Category: Gastroenterology Authors: Hinpetch Daungsupawong Viroj Wiwanitkit Source Type: research

Recent Updates on Pharmacologic Therapy in Nonalcoholic Fatty Liver Disease
Clin Mol Hepatol. 2023 Oct 13. doi: 10.3350/cmh.2023.0356. Online ahead of print.NO ABSTRACTPMID:37828839 | DOI:10.3350/cmh.2023.0356 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - October 13, 2023 Category: Gastroenterology Authors: Young Chang Soung Won Jeong Jae Young Jang Source Type: research

Comment on "ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma."
Clin Mol Hepatol. 2023 Oct 13. doi: 10.3350/cmh.2023.0394. Online ahead of print.NO ABSTRACTPMID:37828840 | DOI:10.3350/cmh.2023.0394 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - October 13, 2023 Category: Gastroenterology Authors: Hinpetch Daungsupawong Viroj Wiwanitkit Source Type: research

Recent Updates on Pharmacologic Therapy in Nonalcoholic Fatty Liver Disease
Clin Mol Hepatol. 2023 Oct 13. doi: 10.3350/cmh.2023.0356. Online ahead of print.NO ABSTRACTPMID:37828839 | DOI:10.3350/cmh.2023.0356 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - October 13, 2023 Category: Gastroenterology Authors: Young Chang Soung Won Jeong Jae Young Jang Source Type: research

Comment on "ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma."
Clin Mol Hepatol. 2023 Oct 13. doi: 10.3350/cmh.2023.0394. Online ahead of print.NO ABSTRACTPMID:37828840 | DOI:10.3350/cmh.2023.0394 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - October 13, 2023 Category: Gastroenterology Authors: Hinpetch Daungsupawong Viroj Wiwanitkit Source Type: research

Recent Updates on Pharmacologic Therapy in Nonalcoholic Fatty Liver Disease
Clin Mol Hepatol. 2023 Oct 13. doi: 10.3350/cmh.2023.0356. Online ahead of print.NO ABSTRACTPMID:37828839 | DOI:10.3350/cmh.2023.0356 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - October 13, 2023 Category: Gastroenterology Authors: Young Chang Soung Won Jeong Jae Young Jang Source Type: research

Comment on "ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma."
Clin Mol Hepatol. 2023 Oct 13. doi: 10.3350/cmh.2023.0394. Online ahead of print.NO ABSTRACTPMID:37828840 | DOI:10.3350/cmh.2023.0394 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - October 13, 2023 Category: Gastroenterology Authors: Hinpetch Daungsupawong Viroj Wiwanitkit Source Type: research

Recent Updates on Pharmacologic Therapy in Nonalcoholic Fatty Liver Disease
Clin Mol Hepatol. 2023 Oct 13. doi: 10.3350/cmh.2023.0356. Online ahead of print.NO ABSTRACTPMID:37828839 | DOI:10.3350/cmh.2023.0356 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - October 13, 2023 Category: Gastroenterology Authors: Young Chang Soung Won Jeong Jae Young Jang Source Type: research

Comment on "ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma."
Clin Mol Hepatol. 2023 Oct 13. doi: 10.3350/cmh.2023.0394. Online ahead of print.NO ABSTRACTPMID:37828840 | DOI:10.3350/cmh.2023.0394 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - October 13, 2023 Category: Gastroenterology Authors: Hinpetch Daungsupawong Viroj Wiwanitkit Source Type: research

Current evidence and the potential role of proton beam therapy for hepatocellular carcinoma
Clin Mol Hepatol. 2023 Oct;29(4):958-968. doi: 10.3350/cmh.2023.0274. Epub 2023 Aug 29.ABSTRACTHepatocellular carcinoma (HCC) is a leading cause of cancer-related death, and external beam radiation therapy has emerged as a promising approach for managing HCC. Proton beam therapy (PBT) offers dosimetric advantages over X-ray therapy, with superior physical properties known as the Bragg peak. PBT holds promise for reducing hepatotoxicity and allowing safe dose-escalation to the tumor. It has been tried in various clinical conditions and has shown promising local tumor control and survival outcomes. A recent phase III trial d...
Source: Clinical and molecular hepatology - October 12, 2023 Category: Gastroenterology Authors: Sung Uk Lee Tae Hyun Kim Source Type: research

Prognostic role of computed tomography analysis using deep learning algorithm in patients with chronic hepatitis B viral infection
CONCLUSION: Deep learning-based automatically measured spleen volume, VAT, and SAT indices may provide various prognostic information in patients with CHB.PMID:37822214 | DOI:10.3350/cmh.2023.0190 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - October 12, 2023 Category: Gastroenterology Authors: Jeongin Yoo Heejin Cho Dong Ho Lee Eun Ju Cho Ijin Joo Sun Kyung Jeon Source Type: research

Letter regarding "Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma"
Clin Mol Hepatol. 2023 Oct 11. doi: 10.3350/cmh.2023.0373. Online ahead of print.NO ABSTRACTPMID:37817733 | DOI:10.3350/cmh.2023.0373 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - October 11, 2023 Category: Gastroenterology Authors: Chi Hsiao Yung-Po Liaw Source Type: research